LipoMedix Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$56K
- Investors
-
1
LipoMedix General Information
Description
Operator of a healthcare company intended to offer cancer therapy based on liposome delivery. The company's therapy involves developing anti-cancer drugs for different types of tumors, especially those derived from the gastrointestinal tract, including the stomach, pancreas, and colorectal, enabling patients to receive safer therapy with a potent anti-tumor effect.
Contact Information
Website
www.lipomedix.com(Operating Subsidiary)
Corporate Office
- Sherman Administration Building
- Derech Ruppin 1, Giv'at Ram
- Jerusalem 9139001
- Israel
Corporate Office
- Sherman Administration Building
- Derech Ruppin 1, Giv'at Ram
- Jerusalem 9139001
- Israel
LipoMedix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Grant | 01-Jul-2019 | $56K | Completed | Generating Revenue | ||
| 5. Later Stage VC | 01-Apr-2019 | Completed | Generating Revenue | |||
| 4. Merger/Acquisition | 24-Jun-2018 | Completed | Generating Revenue | |||
| 3. Grant | 01-May-2016 | Completed | Startup | |||
| 2. Seed Round | Completed | Startup | ||||
| 1. Accelerator/Incubator | Completed | Startup |
LipoMedix Patents
LipoMedix Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2022517352-A | Liposomal compositions and production methods containing liposomal prodrugs of mitomycin c | Pending | 11-Jan-2019 | ||
| AU-2020207026-A1 | Liposome composition comprising liposomal prodrug of mitomycin c and method of manufacture | Inactive | 11-Jan-2019 | ||
| CA-3126211-A1 | Liposome composition comprising liposomal prodrug of mitomycin c and method of manufacture | Active | 11-Jan-2019 | ||
| EP-3908261-A1 | Liposome composition comprising liposomal prodrug of mitomycin c and method of manufacture | Pending | 11-Jan-2019 | ||
| US-12171746-B2 | Liposome composition comprising liposomal prodrug of mitomycin c and method of manufacture | Active | 11-Jan-2019 | A61K31/407 |
LipoMedix Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Innovation Authority | Government | |||
| Integra Holdings | Venture Capital | Minority | ||
| Kepler Holdings | Venture Capital | Minority | ||
| Yissum | Accelerator/Incubator |
LipoMedix FAQs
-
When was LipoMedix founded?
LipoMedix was founded in 2011.
-
Where is LipoMedix headquartered?
LipoMedix is headquartered in Jerusalem, Israel.
-
What industry is LipoMedix in?
LipoMedix’s primary industry is Drug Discovery.
-
Is LipoMedix a private or public company?
LipoMedix is a Private company.
-
What is LipoMedix’s current revenue?
The current revenue for LipoMedix is .
-
How much funding has LipoMedix raised over time?
LipoMedix has raised $1.12M.
-
Who are LipoMedix’s investors?
Innovation Authority, Integra Holdings, Kepler Holdings, and Yissum have invested in LipoMedix.
-
When was LipoMedix acquired?
LipoMedix was acquired on 01-Jul-2019.
-
Who acquired LipoMedix?
LipoMedix was acquired by Rafael Holdings.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process